Algorae Pharmaceuticals Limited has released a press release.
Group 2 Parkinsons trial patients treatment completed
Filed with ASX ·
6ix hasn’t read this filing yet.
Algorae Pharmaceuticals Limited on 6ix
Earlier from Algorae Pharmaceuticals
- Reinstatement to Official Quotation
- Suspension from Official Quotation
- Approval granted for group 2 in Parkinsons trial
- Appendix 4C Quarterly Cash Flow Report 30 September 2016
- Group 1 patients successfully treated in Parkinsons trial
Later from Algorae Pharmaceuticals
- US choroid plexus cells patent application published
- Approval granted for group 3 in Parkinsons trial
- Living Insights Newsletter February 2017
- Treatment completed for all patients in Parkinsons trial
- LCT collaborates with CBR to extend product pipeline
Follow Algorae Pharmaceuticals into a list and get an email when it puts out news.
Follow Algorae Pharmaceuticals